- Research
- Scientific Innovation
- Centers of Distinction
- Current Studies
- Researchers
- Publications
- Research News and Stories
- Brainerd Lakes Clinic
- International Cardiac Outreach, Research and Education (ICORE)
- Running with a mission
- Safer CT Scans
- Sickle Cell Trait and Sudden Death in Young Athletes
- Stem Cell Promise for Angina
- Sudden death in triathlons
- TRANSLATE-ACS Team Recognized
- MHIF Researchers Awarded $2 Million Grant
- Education
- Community Outreach
- News and Events
- About Us
- Donate Now
Learn more about what is involved by downloading our Study Participant Frequently Asked Questions (FAQ) or by contacting the research coordinator.
Download FAQ (PDF 53 KB)
TIME
TIME
Title: TIME
Sponsor: NIH Grant awarded to The Cardiovascular Cell Therapy Research Network
Principal Investigator: Jay H. Traverse, MD
Study Synopsis: This study is testing the safety and effectiveness of giving a person’s own stem cells either 3 or 7 days after a heart attack. Stem cells are simple cells that can help your injured tissues repair themselves and may help grow new blood vessels. The stem cells may help your body repair the damage that occurs with a large heart attack. It is possible that these cells will decrease the size of damage caused to your heart from your heart attack and increase the pumping efficiency of your heart that may be depressed after a heart attack. This repair function may help your heart repair itself and improve the pumping function.
120 patients will be enrolled at 5 centers around the country. Up to 60 patients may be enrolled at Abbott Northwestern Hospital. Your follow up in the study lasts 2 years at the Minneapolis Heart Institute at Abbott Northwestern. Five visits (or 6 for the Day 7 patients) are required. All the visits are completed in one day.
The stem cells are removed from your bone marrow from your hipbone (on your back hip area) and given back to you that same day. The stem cells are given to you through an angioplasty catheter (tube) at the same spot that you had treated for your heart attack either 3 or 7 days earlier.
How do I qualify? Patients who have had their first heart attack that affected the front wall of their heart (often referred to as the “widow-maker”) and have depressed pumping function can be considered for participation. Consideration for participation in this study begins on the day of your heart attack. You must be willing and able to receive treatment on either the 3rd day after your heart attack or the 7th day after your heart attack. Other factors are also checked to see if it is safe for you to participate in the study.
Status: CLOSED TO ENROLLMENT
Whom do I contact for more information? Rachel Olson, RN, MS, CCRC or contact research at 612.863.3980
